Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Brello Health vs EmbraceRX

Brello Health
Graded #482

Lower grade

vs+6.600000000000001
EmbraceRX
Graded #363

Higher grade

The verdict

EmbraceRX takes it — 58.6/100 to 52/100.

EmbraceRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EmbraceRX (Embrace Rx) is a clinician-guided telehealth platform offering pharmacy-compounded medications prescribed online, partnered with the Samaritan MD physician network.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEmbraceRX +16
40
56
Clinical oversightEmbraceRX +4
72
76
Labs & monitoringBrello Health +1
53
52
FulfillmentEven
73
73
Contract termsEmbraceRX +35
20
55
Brello Health · left barEmbraceRX · right bar

The numbers

MetricBrello HealthEmbraceRX
WeighScore52/10058.6/100
GradeCC
Scorecard rank#482#363
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
Coverage35 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Brello Health

Graded #482 · C

Strengths

  • Both semaglutide and tirzepatide available

Where it loses points

  • Pricing not publicly disclosed
EmbraceRX

Graded #363 · C

Strengths

  • Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
  • Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
  • Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)

Where it loses points

  • Pricing not shown upfront — revealed only at checkout after a dose selection
  • Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
  • Compounding pharmacy partner not named ('FDA-registered pharmacies')
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard